isavuconazole and Neuroaspergillosis

isavuconazole has been researched along with Neuroaspergillosis* in 2 studies

Other Studies

2 other study(ies) available for isavuconazole and Neuroaspergillosis

ArticleYear
Isavuconazole Treatment of Cerebral and Pulmonary Aspergillosis in a Pediatric Patient With Acute Lymphoblastic Leukemia: Case Report and Review of Literature.
    Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:6

    Invasive aspergillosis in hematologic pediatric patients is an opportunistic infection that is difficult to treat, with a high mortality rate when localized in the central nervous system. We are describing a 3-year-old girl who was affected by acute lymphoblastic leukemia who developed cerebral and pulmonary aspergillosis during induction chemotherapy. The patient failed first-line voriconazole treatment because of being a CYP2C19 ultrarapid metabolizer and received effective isavuconazole therapy with no notable side effects.

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Child, Preschool; Female; Humans; Neuroaspergillosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pulmonary Aspergillosis; Pyridines; Triazoles

2020
Isavuconazole brain penetration in cerebral aspergillosis.
    The Journal of antimicrobial chemotherapy, 2019, 06-01, Volume: 74, Issue:6

    Topics: Antifungal Agents; Humans; Infectious Encephalitis; Neuroaspergillosis; Nitriles; Permeability; Pyridines; Tissue Distribution; Triazoles

2019